Journey Medical Corporation (DERM) return on equity (ROE)

Return on equity · fiscal 2025
-35.9%

Journey Medical Corporation (DERM) earned a return on equity of -35.9% in fiscal 2025 (the year ended December 31, 2025). That is 37.2 percentage points higher than the -73.1% of fiscal 2024. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-35.9%
Change on fiscal 2024
+37.2 pts
Highest on record
51.3%fiscal 2020
Lowest on record
-174.5%fiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Journey Medical Corporation return on equity (ROE), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was 51.3% in fiscal 2020 and the lowest -174.5% in fiscal 2022. The fiscal 2025 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -73.1%.

History · 6 fiscal years

Return on equity by fiscal year

Journey Medical Corporation return on equity (ROE), year by year

Journey Medical Corporation (DERM) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-35.9% 37.2 pts up
2024-73.1% 54.2 pts down
2023-18.9% 155.5 pts up
2022-174.5% 69.8 pts down
2021-104.6% 156.0 pts down
202051.3%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on DERM

Journey Medical Corporation, figure by figure

Journey Medical Corporation (DERM) overview: price, valuation and scorecard

Journey Medical Corporation return on equity (ROE): questions and answers

What is Journey Medical Corporation's return on equity?

Journey Medical Corporation (DERM) earned a return on equity of -35.9% in fiscal 2025 (the year ended December 31, 2025). That is 37.2 percentage points higher than the -73.1% of fiscal 2024.

Is Journey Medical Corporation's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -73.1%.

What are the highest and lowest return on equity figures on record for Journey Medical Corporation?

Across the 6 fiscal years on record (2020–2025), the highest was 51.3% in fiscal 2020 and the lowest -174.5% in fiscal 2022.

How is Journey Medical Corporation's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For Journey Medical Corporation it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Journey Medical Corporation (DERM) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/DERM/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.